ATYR
Price
$5.25
Change
+$0.15 (+2.94%)
Updated
Jun 26, 01:10 PM (EDT)
Capitalization
454.81M
48 days until earnings call
MBCOF
Price
$0.11
Change
+$0.01 (+10.00%)
Updated
Jun 23 closing price
Capitalization
5.22M
Interact to see
Advertisement

ATYR vs MBCOF

Header iconATYR vs MBCOF Comparison
Open Charts ATYR vs MBCOFBanner chart's image
aTyr Pharma
Price$5.25
Change+$0.15 (+2.94%)
Volume$1.62K
Capitalization454.81M
MARVEL BIOSCIENCES
Price$0.11
Change+$0.01 (+10.00%)
Volume$4K
Capitalization5.22M
ATYR vs MBCOF Comparison Chart in %
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. MBCOF commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Buy and MBCOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ATYR: $5.11 vs. MBCOF: $0.11)
Brand notoriety: ATYR and MBCOF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 133% vs. MBCOF: 17%
Market capitalization -- ATYR: $454.81M vs. MBCOF: $5.22M
ATYR [@Biotechnology] is valued at $454.81M. MBCOF’s [@Biotechnology] market capitalization is $5.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileMBCOF’s FA Score has 1 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • MBCOF’s FA Score: 1 green, 4 red.
According to our system of comparison, MBCOF is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 6 TA indicator(s) are bullish.

  • ATYR’s TA Score: 6 bullish, 3 bearish.

Price Growth

ATYR (@Biotechnology) experienced а -1.16% price change this week, while MBCOF (@Biotechnology) price change was +9.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

ATYR is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATYR($455M) has a higher market cap than MBCOF($5.22M). MBCOF YTD gains are higher at: 48.880 vs. ATYR (41.160). MBCOF has higher annual earnings (EBITDA): -2.02M vs. ATYR (-65.9M). ATYR has more cash in the bank: 76.3M vs. MBCOF (59.5K). MBCOF has less debt than ATYR: MBCOF (1.71M) vs ATYR (13M). ATYR (0) and MBCOF (0) have equivalent revenues.
ATYRMBCOFATYR / MBCOF
Capitalization455M5.22M8,715%
EBITDA-65.9M-2.02M3,267%
Gain YTD41.16048.88084%
P/E RatioN/AN/A-
Revenue00-
Total Cash76.3M59.5K128,235%
Total Debt13M1.71M760%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATYR
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBGUX29.44N/A
N/A
Neuberger Berman Large Cap Growth Adv
GETGX44.28N/A
N/A
Victory Sycamore Established Value R
PQSIX45.88N/A
N/A
PGIM Quant Solutions Large-Cap Index R6
FIDEX13.23N/A
N/A
Fidelity SAI Sustainable U.S. Equity Fd
CWSGX16.32-0.09
-0.55%
Carillon Chartwell Small Cap Growth I

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-3.77%
MGTX - ATYR
43%
Loosely correlated
+1.55%
RZLT - ATYR
43%
Loosely correlated
+2.12%
SLDB - ATYR
40%
Loosely correlated
-2.37%
AURA - ATYR
40%
Loosely correlated
+0.31%
IDYA - ATYR
39%
Loosely correlated
+1.06%
More

MBCOF and

Correlation & Price change

A.I.dvisor tells us that MBCOF and XENE have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBCOF and XENE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBCOF
1D Price
Change %
MBCOF100%
N/A
XENE - MBCOF
20%
Poorly correlated
-1.27%
AWKNF - MBCOF
20%
Poorly correlated
N/A
BSFAF - MBCOF
8%
Poorly correlated
N/A
ZEOX - MBCOF
6%
Poorly correlated
-13.33%
ATYR - MBCOF
5%
Poorly correlated
-3.77%
More